In addition to these common mutations, ALL patients exhibit a higher incidence of DNA methylation mutations (DNMT3A, IDH1, IDH2, TET2, TET3, and WT1) (20, 21). This evidence concerns the gene IDH2 and acute lymphoblastic leukemia.